BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1980316)

  • 1. Use of LeuM1 monoclonal antibody for the diagnosis of Hodgkin's disease.
    Memon GM; Alam SM
    J Pak Med Assoc; 1990 Jul; 40(7):156-9. PubMed ID: 1980316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Reed-Sternberg cells with granulocyte specific monoclonal antibody.
    Memon GM; Alam SM
    J Pak Med Assoc; 1993 Feb; 43(2):32-4. PubMed ID: 8497101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
    Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
    Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (Ki1) lymphoma.
    Hall PA; d'Ardenne AJ; Stansfeld AG
    Histopathology; 1988 Aug; 13(2):161-9. PubMed ID: 3169684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Dorfman RF; Gatter KC; Pulford KA; Mason DY
    Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues.
    Della Croce DR; Imam A; Brynes RK; Nathwani BN; Taylor CR
    Hematol Oncol; 1991; 9(2):103-14. PubMed ID: 1869241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of K-1 (CD-30) marker in Hodgkin's disease.
    Shakoor KA; Saleh A; Khanzada MS
    J Pak Med Assoc; 2002 Oct; 52(10):442-7. PubMed ID: 12553671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
    Zukerberg LR; Collins AB; Ferry JA; Harris NL
    Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Lewis X antigen. A new paraffin section marker for Reed-Sternberg cells.
    Ree HJ; Teplitz C; Khan A
    Cancer; 1991 Mar; 67(5):1338-46. PubMed ID: 1703918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is fascin really a useful marker in distinguishing between classical Hodgkin's lymphoma and various types of non-Hodgkin's lymphomas in difficult cases?
    Idrees R; Ahmad Z; Qureshi A; Ahsan A; Pervez S
    J Clin Pathol; 2010 Jul; 63(7):571-4. PubMed ID: 20591908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.